Breaking News, Collaborations & Alliances

Pfizer, Hisun Launch Off-Patent JV

To develop drug products in China and global markets

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer and Zhejiang Hisun Pharmaceuticals have launched Hisun-Pfizer Pharmaceuticals Co., Ltd., a joint venture to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets. Hisun-Pfizer will utilize Hisun’s product portfolio, market reach and production and commercialization experience with branded generic medicines, and will leverage Pfizer’s R&D, manufacturing, international market promotion and operations.   The JV will focus on R&D and the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters